What is the interpretation of elevated urobilinogen (urine bilirubin byproduct) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Increased urobilinogen in urine or stool is a significant indicator of potential liver dysfunction or hemolytic disorders, and its interpretation should be approached with a thorough diagnostic workup to determine the underlying cause. When interpreting elevated urobilinogen, it is crucial to first determine if the increase is in urine or stool, as this affects the diagnostic approach. In urine, normal values range from 0.1-1.0 Ehrlich units, with higher levels suggesting liver disease (hepatitis, cirrhosis), hemolytic anemia, or severe infections 1. For accurate interpretation, correlate the finding with other liver function tests like bilirubin, ALT, and AST. Some key points to consider in the interpretation and further evaluation include:

  • Correlating urobilinogen levels with clinical symptoms and other laboratory findings to assess for liver disease or hemolysis.
  • Considering additional testing such as a complete blood count to assess for hemolysis and imaging studies like ultrasound or CT scan of the liver if hepatic pathology is suspected.
  • Recognizing that increased urobilinogen occurs because urobilinogen is formed when bilirubin is reduced by intestinal bacteria; when excess bilirubin enters the intestine (as in hemolysis) or when the liver cannot effectively recirculate urobilinogen (as in liver disease), levels rise.
  • If hemolysis is confirmed, further workup for causes like autoimmune hemolytic anemia, sickle cell disease, or G6PD deficiency may be necessary, as suggested by guidelines for evaluating abnormal serum liver chemistries 1. Given the potential for significant morbidity and mortality associated with untreated liver disease or hemolytic disorders, a thorough and expeditious evaluation is essential in patients with significant symptoms or evidence of chronic or decompensated liver disease.

From the Research

Interpreting Increased Urobilinogen

Increased urobilinogen can be an indicator of various health issues, including liver disease and hemolytic anemia.

  • Urobilinogen is a byproduct of bilirubin breakdown, and its levels can be measured in urine, feces, bile, and serum 2.
  • Elevated urobilinogen levels may suggest increased bilirubin production, which can occur in cases of hemolysis or liver dysfunction 3, 4.
  • A study found that urine urobilinogen assays can be used as a screening test for liver function test abnormalities, with a sensitivity of 70-74% and specificity of 77-87% 5.
  • In cases of hemolytic anemia, increased urobilinogen levels can be accompanied by other laboratory findings such as anemia, reticulocytosis, and elevated unconjugated bilirubin 4.
  • The diagnosis of hemolysis is based on the presence of anemia with sustained reticulocytosis, and additional findings can include marrow erythroid hyperplasia and decreased haptoglobin and hemopexin 4.

Clinical Utility of Urobilinogen Assays

  • Urine urobilinogen assays can be used to screen for liver function test abnormalities, with a positive predictive value of 83-86% 5.
  • A normal/abnormal threshold of 2.0/4.0 mg/dL can be used to determine the clinical utility of urine urobilinogen as a screen 5.
  • The measurement of urobilinogen levels can be performed using direct spectrophotometry or spectrofluorometry of a zinc complex, with high sensitivity and specificity 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Quantitation of urobilinogen in feces, urine, bile and serum by direct spectrophotometry of zinc complex.

Clinica chimica acta; international journal of clinical chemistry, 1991

Research

Hemolytic anemias. Diagnosis and management.

The Medical clinics of North America, 1992

Related Questions

What is the normal level of urobilinogen (urine dipstick test) in urine?
What are the benign reasons for urobilinogen in urine?
What are the implications of elevated urobilinogen in a urinalysis?
What are the causes of hyperbilirubinemia (elevated bilirubin)?
What does bilirubin (Bili) in urine indicate and how is it treated?
What is the etiology of tachycardia (rapid heart rate) with hypotension (low blood pressure) versus tachycardia with hypertension (high blood pressure)?
What causes postprandial hyperthermia (elevated body temperature after meals)?
What is the cause of the inflamed skin behind the left ear with a rash and sweating, presenting with red and white areas?
What is the recommended dose of Aspirin (acetylsalicylic acid) for a patient presenting with a subacute stroke in the Emergency Room (ER)?
What is the diagnosis for a patient with cramping pain in the left knee, present for over 15 years, exacerbated by activity, with a current pain scale of 5/10 and a worst pain scale of 10/10?
What are the most important evidence-based cardiac medications to re-introduce in a 91-year-old patient with paroxysmal supraventricular tachycardia (PSVT)/atrial fibrillation, sinus bradycardia with a Dual-Chamber (DDD) pacemaker, right-sided heart failure, pulmonary hypertension, preserved ejection fraction (EF), and a history of impaired renal function, who is experiencing hypovolemia and is currently on Digoxin, Spironolactone, Ramipril, Dapagliflozin, Apixaban (apixaban), and Metoprolol (metoprolol)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.